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Dear Editor,
Next-generation sequencing (NGS) is rapidly being adapted in 
clinical practice, and numerous clinical laboratories are using 
this technology to assess patients with acute myeloid leukemia 
(AML). Among recurrent somatic mutations in AML, the FLT3 
internal tandem duplication (ITD) has major clinical implications 
and is associated with adverse outcomes [1-3]. Identification of 
the mutation is critical for risk stratification and the decision of 
early hematopoietic stem cell transplantation [2, 3]. Furthermore, 
as activated kinase targets such as FLT3 and JAK are under ac-
tive clinical investigation [4, 5], it has become increasingly im-
portant to identify activating FLT3 mutations. During NGS, how-
ever, accurate mapping and consequent variant calling is not al-
ways possible because the duplication size could be small or 
large, and the inserted segment is essentially, but not necessar-
ily, a part of the normal reference sequence. 
We performed NGS for patients with AML. Bone marrow aspi-
rates of 229 patients diagnosed as having AML between March 
2017 and February 2018 in Severance Hospital, Seoul, Korea, 
were prospectively collected after obtaining informed consent. 
The study was approved by our Institutional Review Board (4-
2016-0869). Thirty patients harbored the FLT3 ITD mutation, 
identified by PCR and fragment analysis. To determine whether 
FLT3 ITD mutations could be accurately identified from targeted 
multigene NGS data, we analyzed the NGS data with different 
algorithms and compared the results with those of PCR and frag-
ment analysis, a current standard test. 
NGS was performed using the NextSeq 550 instrument (Illu-
mina, San Diego, CA, USA), with custom probes (Celemics, Seoul, 
Korea) for AML. The Burrows-Wheeler alignment tool (0.7.12) 
was used for sequence alignment [6]. GATK MuTect2 (3.8-0), 
and Pindel (0.2.0) algorithms were used to detect FLT3 ITD mu-
tations [7, 8], which were implemented in the DxSeq algorithm 
(Dxome, Seoul, Korea). PCR amplification and fragment detec-
tion analyses were performed using a 3130 Genetic Analyzer 
(Applied Biosystems, Foster City, CA, USA) and GeneMapper 
3.2 software (Applied Biosystems), with a modified protocol based 
on that previously described [9].
The median depth of the FLT3 gene was 4,412×, ranging from 
2,626× to 7,595×. GATK MuTect2 detected FLT3 ITD muta-
tions in 15 of 30 cases, most of which had a relatively short du-
plicated segment. The Pindel algorithm detected FLT3 ITD mu-
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tations in all cases. The duplication ranged from 18 to 201 bp, 
and the mutant allele burden was estimated to be 0.028–0.930 
on PCR fragment analysis. The duplication sizes estimated us-
ing Pindel algorithm were concurrent with that by PCR fragment 
analysis in all cases, while the mutant allele fraction calculated 
using Pindel tended to be lower than that obtained by PCR frag-
ment analysis (Fig. 1). Values from the two methods were not 
strongly correlated (Fig. 1).
The different results of the two variant callers stem from their 
algorithms. GATK MuTect2 helps detect insertions and deletions 
(indels), using initially identified indels during read alignment 
[10]. Owing to process limitations among read pairs with discor-
dant sizes or orientations mapped with high confidence, the al-
gorithm can detect only insertions contained entirely within indi-
vidual read alignments, typically less than approximately 15–20 
bp. In contrast, Pindel is a pattern-growth algorithm using read 
pairs, wherein one is partially or completely unaligned [8]. Inclu-
sion of these reads is critical for identifying medium-size inser-
tions, such as those in FLT3 ITD mutations, because this size 
range is too large to be detected on the basis of indels within 
single reads and is often too small for detection by analysis of 
discordant insert sizes. 
However, the Pindel algorithm tends to underestimate the mu-
tant allele fraction. Inaccurate estimation of allele burden is a 
major disadvantage because the FLT3 ITD mutant allele burden 
is one of the prognostic markers for AML [2, 3]. Identification of 
FLT3 ITD is challenging because wild-type DNA yields shorter 
amplicons than mutant DNA, thereby having a competitive ad-
vantage leading to a PCR bias in NGS analyses adopting ampli-
con-based enrichment. NGS analyses with hybrid capture probes 
may be limited in capturing mutant DNAs with large insertions 
or deletions partly owing to large mismatches between capture 
probes and mutant DNAs. The capture bias tends to increase 
with an increase in duplication length. In one case, this differ-
ence was the largest at a 138-bp insertion. Although the true 
mutant allele burden could be deduced from the variant allele 
frequency of each tool, the existence of a larger portion of leu-
kemic cells harboring the mutation warrants consideration. 
In conclusion, the Pindel algorithm was highly effective in de-
tecting FLT3 ITD mutations in the NGS assessment of AML pa-
tients and was superior to GATK MuTect2. Although the mutant 
allele fraction calculated tended to be lower than that obtained 
by PCR fragment analysis, Pindel has clinical utility for identify-
ing clinically significant FLT3 ITD mutations in a single NGS anal-
ysis. 
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